Effect of benzodiazepines on cyclic GMP formation in rat cerebellar slices.
Cyclic 3',5' guanosine monophosphate (cGMP) levels, stimulated in brain slices by ouabain, potassium, and sodium azide depolarization, have been found to be inhibited in a dose-dependent fashion by both behaviorally active and inactive benzodiazepines. ED50's for these benzodiazepines bear no relation to potencies established from receptor membrane binding studies; however, these values do correspond to ED50's calculated for several known membrane stabilizing agents tested in this system. The concentration of [3H]flunitrazepam necessary to saturate the benzodiazepine receptor in identical  slice preparations is considerably lower than that needed to initiate inhibition of depolarization-induced cGMP stimulation. Some of the reported in vivo actions of benzodiazepines on cGMP formation may be the result of membrane stabilizing actions of the benzodiazepines or mediated indirectly.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000378:metabolism / Q000494:pharmacology*; D001569:Benzodiazepines; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011955:Receptors, Drug / Q000378:metabolism; D011963:Receptors, GABA-A
D014151:Anti-Anxiety Agents; D011955:Receptors, Drug; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D010042:Ouabain; D006152:Cyclic GMP